Colonic lymphoid follicles and NOD2/CARD15 mutational status in Crohn's disease

British Journal of Surgery

Volumn 96, Issue 6, 2009, Pages 655-662

  Nascimbeni, R ^a   Villanacci, V ^a   Bassotti, G ^b   Fisogni, S ^a   Gervasi, M ^a   Rossi, E ^a   Di Lorenzo, D ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LYMPH FOLLICLE; MALE; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; COLON; CROHN DISEASE; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PROSPECTIVE STUDIES;

EID: 66749152038     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6615     Document Type: Article

References (32)

1. Newberry RD, Lorenz RG. Organizing a mucosal defense. Immunol Rev 2005; 206: 6-21. (Pubitemid 41105160)
2. Eberl G. From induced to programmed lymphoid tissue: the long road to preempt pathogens. Trends Immunol 2007; 28: 423-428. (Pubitemid 47444552)
3. Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin- sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol 2003; 170: 5475-5482. (Pubitemid 36617835)
4. Pabst O, Herbrand H, Friedrichsen M, Velaga S, Dorsch M, Berhardt G et al. Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling. J Immunol 2006; 177: 6824-6832. (Pubitemid 44715047)
5. Nascimbeni R, Di Fabio F, Di Betta E, Mariani P, Fisogni S, Villanacci V. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 2005; 18: 681-685. (Pubitemid 40676380)
6. Dukes C, Bussey HJR. The number of lymphoid follicles of the human large intestine. J Pathol Bacteriol 1926; 29: 111-116.
7. Yeung MM, Melgar S, Baranov V, Oberg A, Danielsson A, Hammarström S et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut 2000; 47: 215-227. (Pubitemid 30489765)
8. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
9. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606. (Pubitemid 32531409)
10. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889-894. (Pubitemid 38970589)
11. Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247-254.
12. Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 2006; 12: 641-650. (Pubitemid 43977746)
13. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann NY Acad Sci 2006; 1072: 9-18. (Pubitemid 44448439)
14. Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS ONE 2007; 2: e523.
15. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ et al. A simple classification of Crohn's disease: report of the Working Party of the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
16. Xiao W, Oefner PJ. Denaturing high-performance liquid chromatography: a review. Hum Mutat 2001; 17: 439-474. (Pubitemid 32480082)
17. Cremonesi L, Foglieni B, Fermo I, Cozzi A, Paroni R, Ruggeri G et al. Identification of two novel mutations in the 5′-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematologica 2003; 88: 1110-1116. (Pubitemid 37362542)
18. Tanaka M, Saito H, Kusumi T, Fukuda S, Shimoyama T, Sasaki Y et al. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol 2001; 16: 1353-1359. (Pubitemid 34107402)
19. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, Schlee M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658-1664. (Pubitemid 39434112)
20. Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003; 52: 840-846. (Pubitemid 36613491)
21. Rosenthiel P, Fantini M, Bräutigam K, Kübacher T, Waetzig GH, Seegert D et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human epithelial cells. Gastroenterology 2003; 124: 1001-1009. (Pubitemid 36389803)
22. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867-874. (Pubitemid 34267268)
23. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJP, Mascheretti et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359: 1661-1665. (Pubitemid 34518526)
24. Fujimura Y, Kamoi R, Iida M. Pathogenesis of aphtoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 1996; 38: 724-732. (Pubitemid 26167481)
25. Van Kruiningen HJ, West AB, Freda BJ, Holmes KA. Distribution of Peyer's patches in the distal ileum. Inflamm Bowel Dis 2002; 8: 180-185. (Pubitemid 34546044)
26. Van Kruiningen HJ, Ganley LM, Freda BJ. The role of Peyer's patches in the age-related incidence of Crohn's disease. J Clin Gastroenterol 1997; 25: 470-475. (Pubitemid 27528135)
27. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734. (Pubitemid 40194644)
28. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y Fuss IJ, Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006; 25: 473-485. (Pubitemid 44355006)
29. Mukherjee S, Vaishnava S, Hooper LV. Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 2008; 65: 3019-3027.
30. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189: 1169-1180. (Pubitemid 29198256)
31. Spahn TW, Herbst H, Rennert PD, Lügering N, Maaser C, Kraft M et al. Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol 2002; 161: 2273-2282. (Pubitemid 35434871)
32. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterology 1990; 37: 18-31. (Pubitemid 20092204)